Axsome Therapeutics (AXSM) Return on Sales (2022 - 2026)

Axsome Therapeutics' Return on Sales history runs 5 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (up 1.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q1 2026 at Axsome Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2023 to a low of 1.5% in Q4 2024.
• A 5-year average of 0.1% and a median of 0.01% in 2024 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales sank 148 bps in 2024 and jumped 150 bps in 2025, its largest moves.
• Axsome Therapeutics' Return on Sales stood at 0.03% in 2022, then jumped by 45 bps to 0.01% in 2023, then plunged by 10763 bps to 1.5% in 2024, then surged by 100 bps to 0.0% in 2025, then tumbled by 131 bps to 0.0% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison